Arcus Biosciences Announces Option and License Agreement with Taiho...
HAYWARD, Calif. Arcus Biosciences, a US-based biotechnology company focused on the discovery and development of innovative cancer immunotherapies, announced today that it has entered into an option...
View ArticleEagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride...
WOODCLIFF LAKE, N.J. & TOKYO Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) and SymBio Pharmaceuticals Limited (“SymBio”) (Tokyo Stock Exchange/JASDAQ 4582) today announced...
View ArticleSun Pharma Odomzo® (Sonidegib) New Label Approval Shows Sustained Duration of...
MUMBAI, India Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries or associate companies) today announced...
View ArticleAvita Medical and BARDA Execute a US$24.3m Contract Option
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today...
View Article十年磨一剑,Biosafe Defenses LLC宣布新突破性消毒剂
新墨西哥州阿尔伯克基 (美国商业资讯)–全球领先的家用、医院用和工业用全新光敏消毒剂、杀菌剂和抗微生物剂生产商Biosafe Defenses LLC(前身为Biosafe Technologies LLC)刚刚宣布在美国斩获第九项关键专利,名为“阳离子共轭聚合物与使用方法”(Conjugated Polyelectrolytes and Methods of Using the...
View ArticleExelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical...
SOUTH SAN FRANCISCO, Calif. Exelixis, Inc. (NASDAQ: EXEL) today announced that its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has reported positive top-line results from a phase 3...
View ArticleKonica Minolta Accelerates Expansion of Precision Medicine Business Through...
TOKYO & BOSTON Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902; ISIN: JP3300600008) and Boston-based Invicro LLC (“Invicro”) today announced that they have concluded an agreement whereby...
View ArticleInternationally Renowned Virologist Christian Bréchot Appointed President of...
MELBOURNE, Australia The Global Virus Network (GVN), an international coalition of the world’s foremost medical virologists, comprising 40 Centers of Excellence in 24 countries, dedicated to...
View ArticleChina Food and Drug Administration Approves Gilead’s Sovaldi® (Sofosbuvir)...
FOSTER CITY, Calif. Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China Food and Drug Administration (CFDA) has approved Sovaldi® (sofosbuvir 400mg), a once-daily oral nucleotide...
View ArticleEvaluate Ltd: Worldwide Medtech Sales Forecast to Reach $522 Billion by 2022...
LONDON & BOSTON & TOKYO & SAN FRANCISCO The “EvaluateMedTech World Preview 2017, Outlook to 2022” report from life science commercial intelligence firm Evaluate Ltd, reveals Medtronic...
View ArticleSanBio Names Mohammad El-Kalay New Technical Operations SVP
MOUNTAIN VIEW, Calif. SanBio, Inc., a leader in regenerative cell therapies, today announced the appointment of Mohammad El-Kalay, PhD, as Senior Vice President of Technical Operations. In this...
View ArticleAustralian Biotech Leads New Hope for Influenza Control
MELBOURNE, Australia Australian researchers could pave the way for a new approach to influenza control with positive results presented today from preclinical studies demonstrating the effectiveness...
View ArticleLombard Medical’s New Delivery System for Aorfix™ Endovascular Aortic...
OXFORDSHIRE, England Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular abdominal aortic aneurysm (AAA) endovascular repair products, today announced the...
View ArticleAkebia Announces Positive Top-Line Results from Phase 2 Study of Vadadustat...
CAMBRIDGE, Mass. Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of...
View ArticleMedherantがTEPI Patch®薬物送達システムの評価を目的に日本の大手経皮吸収パッチ企業と契約
英コベントリー (ビジネスワイヤ) — 次世代型経皮薬物送達のリーダー企業Medherantは、貼付剤開発製造の世界最大手の一角を占める日本の経皮吸収パッチ企業(以下「同社」)と契約を締結しました。同社が供給する薬物を送達する当社製TEPI Patch®技術の潜在力の評価を実施することが目的です。...
View ArticleEnanta Announces that AbbVie’s MAVIRET™ (glecaprevir/pibrentasvir) Received...
WATERTOWN, Mass. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver...
View ArticleCorindus Announces Opening of First International Robotic Training Center
WALTHAM, Mass. Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today the opening of the first international CorPath GRX Robotic...
View ArticleVitruvias Therapeutics and Sunny Pharmtech Receive First FDA Generic Drug...
AUBURN, Al. & TAIPEI, Taiwan Sunny Pharmtech Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvias Therapeutics LLC, a generic drug development company, announced...
View Articledüber Technologies Inc.与Vacone Real Estate签订5,000万美元融资协议用于建立15家配送中心
西雅图 (美国商业资讯)–服务于大麻行业的软件即服务(SaaS)提供商düber Technologies Inc.今天宣布,该公司与Vacone Real Estate签订了一份5,000万美元的融资协议,用于华盛顿州、俄勒冈州、加州、内华达州和亚利桑那州15处大麻配送中心的收购、装修和主租赁。...
View Article